American College of Cardiology
Jun 11, 2026, 23:38
Why the New 2026 CKM Syndrome Guideline Changes Everything for Chronic Disease Prevention – American College of Cardiology
American College of Cardiology shared a post on LinkedIn:
“The 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome is the first ever to address the ‘interrelated condition characterized by the interconnections among metabolic risk factors (including obesity and type 2 diabetes), chronic kidney disease (CKD) and cardiovascular disease.’
The document retires, replaces and expands upon the 2013 Guideline for the Management of Overweight and Obesity in Adults.
Read the full guideline in JACC.”
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 27, 2026, 03:42Koson Tony Sriamporn: A Milestone for Inclusive Blood Donor Eligibility
-
Jul 27, 2026, 03:34Wolfgang Miesbach: A Standout Talk by Jeffrey Weitz at ISTH 2026
-
Jul 26, 2026, 23:18Mohammadmahdi Sabahi: Proud to Share Our Complete Cushing’s Disease Research Collection
-
Jul 26, 2026, 22:59Mahmood Naseri: The Results of the 2nd Clinical Trial on AriClot Are Now Live in Burns Journal
-
Jul 26, 2026, 16:26Novi Yanti Sari: When MPNs Affect the Heart
-
Jul 26, 2026, 16:21Beyond Drugs: Can Museums Become a Medical Prescription?
-
Jul 26, 2026, 14:45Sarah Giorgia Grazia Giannone: An Exciting Chapter in Gene Therapy Research
-
Jul 26, 2026, 14:21Javed Anees: Cerebral Collateral Circulation in Acute Ischemic Stroke
-
Jul 26, 2026, 14:11André Picard։ Canadian Blood Supplies Drop Sharply, Urgent Donor Appeal Issued